Oct 22, 2019
Ionis Pharmaceuticals to hold third quarter 2019 financial results webcast
Oct 09, 2019
Ionis' Factor XI anti-thrombotic medicine advances with Bayer following positive clinical results
Aug 27, 2019
Ionis licenses hepatitis B program to GSK
Aug 07, 2019
Ionis Reports Second Quarter 2019 Financial Results
Jul 30, 2019
Ionis Pharmaceuticals to hold second quarter 2019 financial results webcast
Jun 18, 2019
Ionis Pharmaceuticals to present at the BMO Prescription for Success Healthcare Conference
Jun 12, 2019
Ionis announces appointment of Joan E. Herman to its board of directors
May 01, 2019
Positive clinical data at AAN 2019 reinforces Ionis' commitment to delivering life-changing medicines to patients with neurological diseases
Mar 25, 2019
Ionis announces appointment of Brett P. Monia Ph.D. to its board of directors
Mar 07, 2019
Ionis Pharmaceuticals to Present at Upcoming Investor Conferences
Feb 13, 2019
Ionis Pharmaceuticals to Hold 2018 Financial Results Webcast
Jan 02, 2019
Ionis Pharmaceuticals to Present at 37th Annual J.P. Morgan Healthcare Conference
Dec 20, 2018
Ionis Announces Plans for Management Transitions in 2020
Nov 27, 2018
First-in-class therapies using advanced antisense chemistries highlighted at 2018 American Society of Hematology Annual Meeting
Nov 13, 2018
Ionis Pharmaceuticals to Present at Jefferies 2018 London Healthcare Conference
Nov 09, 2018
Ionis Pharmaceuticals to Host Investor Day
Nov 07, 2018
Ionis Pharmaceuticals to Present at Upcoming Investor Conferences
Nov 06, 2018
Ionis Reports Third Quarter 2018 Financial Results
Oct 24, 2018
Ionis Pharmaceuticals to Hold Third Quarter 2018 Financial Results Webcast
Oct 23, 2018
Dr. C. Frank Bennett Receives Leslie Gehry Brenner Prize for Innovation in Science